The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Valentin Feichtenschlager(Cancer Research Institute), Susana Ortiz‐Urda(University of California, San Francisco)

Molecular Cancer

February 21, 2024

10.1186/s12943-024-01955-7

Cited by 14

Related Papers

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

|JAMA Dermatology|2015|452

Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies

|Communications Medicine|2025|2

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

|Research Square|2023|1